tiprankstipranks
Trending News
More News >
TherapeuticsMD (TXMD)
NASDAQ:TXMD
US Market

TherapeuticsMD (TXMD) Ratios

Compare
2,245 Followers

TherapeuticsMD Ratios

TXMD's free cash flow for Q3 2025 was $1.00. For the 2025 fiscal year, TXMD's free cash flow was decreased by $ and operating cash flow was $0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Mar 23Dec 21
Liquidity Ratios
Current Ratio
2.46 1.92 1.72 1.18 0.47
Quick Ratio
2.46 1.92 1.72 1.18 0.44
Cash Ratio
1.44 0.98 0.63 0.81 0.26
Solvency Ratio
0.06 -0.15 -0.70 2.05 -0.65
Operating Cash Flow Ratio
0.42 0.14 -7.02 -0.09 -0.58
Short-Term Operating Cash Flow Coverage
1.93 0.45 0.00 0.00 -0.79
Net Current Asset Value
$ 942.00K$ -1.53M$ -2.23M$ 36.00K$ -143.63M
Leverage Ratios
Debt-to-Assets Ratio
0.17 0.18 0.18 0.10 1.17
Debt-to-Equity Ratio
0.24 0.26 0.27 0.25 -2.11
Debt-to-Capital Ratio
0.19 0.21 0.21 0.20 1.90
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.41 1.42 1.48 2.57 -1.81
Debt Service Coverage Ratio
-0.84 -1.80 0.00 0.00 -0.32
Interest Coverage Ratio
-387.86 -501.05 0.00 0.00 -2.42
Debt to Market Cap
0.04 0.16 0.00 0.00 1.31
Interest Debt Per Share
0.56 0.62 0.77 0.97 28.97
Net Debt to EBITDA
0.65 -0.71 -0.45 -2.47 -1.87
Profitability Margins
Gross Profit Margin
100.00%100.00%100.00%98.00%45.51%
EBIT Margin
-48.68%-198.30%-654.61%15.24%-2781.85%
EBITDA Margin
-34.84%-169.39%-620.93%16.96%-2753.25%
Operating Profit Margin
-97.10%-270.30%-654.61%1.70%-3092.77%
Pretax Profit Margin
0.36%-133.05%-594.62%1.54%-3082.20%
Net Profit Margin
10.80%-123.85%-789.40%160.08%-6700.93%
Continuous Operations Profit Margin
2.61%-131.29%-591.32%1.54%-3082.20%
Net Income Per EBT
3020.00%93.09%132.76%10428.03%217.41%
EBT Per EBIT
-0.37%49.22%90.84%90.18%99.66%
Return on Assets (ROA)
0.78%-5.62%-23.73%123.81%-101.74%
Return on Equity (ROE)
1.11%-7.97%-35.09%318.69%184.16%
Return on Capital Employed (ROCE)
-8.05%-14.14%-23.38%2.73%95.39%
Return on Invested Capital (ROIC)
-7.80%-13.31%-22.35%2.65%-74.92%
Return on Tangible Assets
0.87%-6.32%-27.62%134.10%-106.21%
Earnings Yield
1.16%-21.99%-43.75%221.92%-120.33%
Efficiency Ratios
Receivables Turnover
0.76 0.49 0.42 0.00 0.07
Payables Turnover
0.00 0.00 0.00 0.65 0.42
Inventory Turnover
0.00 0.00 0.00 0.00 0.18
Fixed Asset Turnover
0.51 0.29 0.19 9.14 0.28
Asset Turnover
0.07 0.05 0.03 0.77 0.02
Working Capital Turnover Ratio
0.35 0.36 0.19 -1.12 -0.08
Cash Conversion Cycle
478.44 738.29 866.24 -564.87 6.24K
Days of Sales Outstanding
478.44 738.29 866.24 0.00 5.13K
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 1.98K
Days of Payables Outstanding
0.00 0.00 0.00 564.87 878.13
Operating Cycle
478.44 738.29 866.24 0.00 7.12K
Cash Flow Ratios
Operating Cash Flow Per Share
0.18 0.06 -4.61 -0.45 -18.57
Free Cash Flow Per Share
0.18 0.06 0.00 -0.49 -18.57
CapEx Per Share
0.00 0.00 4.61 0.04 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 0.00 1.09 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 -1.00 -11.49 -4.35K
Capital Expenditure Coverage Ratio
0.00 0.00 -1.00 -11.49 -4.35K
Operating Cash Flow Coverage Ratio
0.32 0.10 -6.01 -0.47 -0.75
Operating Cash Flow to Sales Ratio
0.74 0.42 -36.97 -0.06 -57.45
Free Cash Flow Yield
7.94%7.38%0.00%-8.78%-103.19%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
86.23 -4.55 -2.29 0.45 -0.83
Price-to-Sales (P/S) Ratio
9.31 5.63 18.04 0.72 55.69
Price-to-Book (P/B) Ratio
0.95 0.36 0.80 1.44 -1.53
Price-to-Free Cash Flow (P/FCF) Ratio
12.59 13.55 0.00 -11.38 -0.97
Price-to-Operating Cash Flow Ratio
12.59 13.55 -0.49 -12.38 -0.97
Price-to-Earnings Growth (PEG) Ratio
0.52 0.07 0.02 >-0.01 0.03
Price-to-Fair Value
0.95 0.36 0.80 1.44 -1.53
Enterprise Value Multiple
-26.09 -4.03 -3.36 1.78 -3.90
Enterprise Value
25.41M 12.03M 27.17M 21.16M 276.07M
EV to EBITDA
-26.09 -4.03 -3.36 1.78 -3.90
EV to Sales
9.09 6.83 20.87 0.30 107.29
EV to Free Cash Flow
12.29 16.44 0.00 -4.77 -1.87
EV to Operating Cash Flow
12.29 16.44 -0.56 -5.19 -1.87
Tangible Book Value Per Share
2.03 2.00 2.22 3.12 -12.66
Shareholders’ Equity Per Share
2.37 2.37 2.80 3.89 -11.76
Tax and Other Ratios
Effective Tax Rate
-6.30 0.01 <0.01 0.00 0.00
Revenue Per Share
0.24 0.15 0.12 7.75 0.32
Net Income Per Share
0.03 -0.19 -0.98 12.41 -21.66
Tax Burden
30.20 0.93 1.33 104.28 2.17
Interest Burden
>-0.01 0.67 0.91 0.10 1.11
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.54 0.00 0.00 0.83 28.27
Stock-Based Compensation to Revenue
<0.01 0.00 0.00 0.17 0.00
Income Quality
9.80 -0.32 6.25 -3.80 1.86
Currency in USD